A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth

Madhu Lal-Nag1, Lauren McGee1, Rajarshi Guha1

  • 11 Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, MD, USA.

Insights

The tumor microenvironment significantly impacts ovarian cancer drug resistance. Researchers found that drug efficacy varies based on the tumor microenvironment and cell structure, highlighting the need for advanced 3D models in drug screening.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • The tumor microenvironment (TME) is crucial for tumor growth, metastasis, and drug resistance.
  • Understanding the TME's influence on drug response is vital for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the effect of the ovarian cancer metastatic microenvironment on drug responses.
  • To evaluate how different drug classes affect cancer cell proliferation within a 3D microenvironment model.

Main Methods:

  • Utilized a multilayered 3D primary cell culture model simulating the human ovarian cancer metastatic microenvironment.
  • Screened a panel of oncology drugs against ovarian cancer cells in various conditions: monolayers, spheroids, and a 3D omentum model.

Main Results:

  • Drug efficacy varied significantly depending on the cellular context and cell adhesion mode.
  • Certain drug targets were more effective in cells lacking the metastatic microenvironment, while others were less effective in preformed spheroids.

Conclusions:

  • The tumor microenvironment and cell adhesion play critical roles in ovarian cancer drug resistance.
  • Drug screening should employ models that accurately mimic the tissue composition of metastatic sites for better prediction of in vivo efficacy.

Related Concept Videos